Vaping clinical trials at University of California Health
3 research studies open to eligible people
Acute Effects of TCIG vs ECIG in PLWH
open to eligible people ages 21-45
Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.
at UCLA
Secondhand Effects of E-Hookah Aerosol
open to eligible people ages 21-49
In the United States, exposure to secondhand smoke accounts for greater than 35,000 deaths annually from cardiovascular disease in never-smokers. Electronic (e-) hookahs are a new category of vaping devices gaining popularity among youth. While more is known on the acute effects of active hookah smoking and the literature is emerging on active e-hookah vaping, virtually nothing is known about the acute cardiovascular effects of secondhand exposure to e-hookah aerosol. The study aims to examine the acute effects of secondhand exposure of e-hookah aerosol on endothelial and vascular function. Eligible volunteers will be invited to participate in a total of 3 study visits (2-3 hours each): e-hookah aerosol exposure, charcoal-heated hookah smoke exposure (both delivered by a hookah smoking/vaping machine) and smoke-free room air. Non-invasive blood pressure and blood flow measurements will be taken before and after the exposure sessions.
at UCLA
Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents
open to eligible people ages 13-21
Social media based intervention to support teens in their efforts to quit vaping.
at UCSF
Our lead scientists for Vaping research studies include Pamela Ling, MD Holly R Middlekauff, MD.
Last updated: